A University of Zurich spin-off, KOVE medical develops an implantable device that closes the foetal membrane after in utero surgery to reduce the risk of preterm birth. The start-up has closed a CHF 1.6 million seed round from a syndicate of business angels to reach first human studies.
- Announced on
- Round
- Seed
- Amount
- CHF 1.6 M
- Location
- canton of Zurich
- Sector
- Health & medtech
Investors
The investors were not named in the announcement.
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic